Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2016

01.01.2016 | Breast Oncology

Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without Reconstruction

verfasst von: Merisa Piper, MD, Anne Warren Peled, MD, Hani Sbitany, MD, Robert D. Foster, MD, Laura J. Esserman, MD, MBA, Elissa R. Price, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Reconstruction of lumpectomy defects with reduction mammoplasty techniques can improve aesthetic outcomes and patient satisfaction. However, one concern with the substantial tissue rearrangement required is the possible difficulty with mammographic follow up and/or increased recommendations for future biopsies.

Methods

We performed a retrospective review of 49 patients who underwent oncoplastic reduction mammoplasty between 2001 and 2009 who were age-matched to patients who underwent lumpectomy without reconstruction. Mammography reports at 6 months, 1, 2, and 5 years postoperatively were reviewed for predominant findings, Breast Imaging Reporting and Data System final assessments, and recommendations for biopsy.

Results

There was no significant difference in abnormal mammographic findings prompting biopsy between the two cohorts at 6 months, 2 years, and 5 years postoperatively (p > 0.05). Biopsy rates over the 5-year period did not differ significantly between the two cohorts [9 (18 %) lumpectomy cohort, 12 (24 %) oncoplastic cohort, p = 0.46]. Overall cancer-to-biopsy ratio was 33 % in the lumpectomy cohort and 42 % in the oncoplastic cohort (p = 1.00).

Conclusions

Although substantial tissue rearrangement is performed at the time of oncoplastic reduction mammoplasty, our results reveal no increased incidence of postoperative mammographic abnormalities or unnecessary biopsies compared to lumpectomy alone. This demonstrates that fear of increasing mammographic abnormalities and biopsies after reduction mammoplasty is unfounded and should not prevent utilization of this technique if it can optimize cosmetic outcomes and extend the option of breast conservation.
Literatur
1.
Zurück zum Zitat Patel KM, Hannan CM, Gatti ME, Nahabedian MY. A head-to-head comparison of quality of life and aesthetic outcomes following immediate, staged-immediate, and delayed oncoplastic reduction mammaplasty. Plast Reconstr Surg. 2011;127(6):2167–75.PubMedCrossRef Patel KM, Hannan CM, Gatti ME, Nahabedian MY. A head-to-head comparison of quality of life and aesthetic outcomes following immediate, staged-immediate, and delayed oncoplastic reduction mammaplasty. Plast Reconstr Surg. 2011;127(6):2167–75.PubMedCrossRef
2.
Zurück zum Zitat Veiga DF, Veiga-Filho J, Ribeiro LM, et al. Quality-of-life and self-esteem outcomes after oncoplastic breast-conserving surgery. Plast Reconstr Surg. 2010;125(3):811–7.PubMedCrossRef Veiga DF, Veiga-Filho J, Ribeiro LM, et al. Quality-of-life and self-esteem outcomes after oncoplastic breast-conserving surgery. Plast Reconstr Surg. 2010;125(3):811–7.PubMedCrossRef
3.
Zurück zum Zitat Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014;72(2):145–9.PubMedCrossRef Losken A, Dugal CS, Styblo TM, Carlson GW. A meta-analysis comparing breast conservation therapy alone to the oncoplastic technique. Ann Plast Surg. 2014;72(2):145–9.PubMedCrossRef
4.
Zurück zum Zitat Losken A, Pinell XA, Eskenazi B. The benefits of partial versus total breast reconstruction for women with macromastia. Plast Reconstr Surg. 2010;125(4):1051–6.PubMed Losken A, Pinell XA, Eskenazi B. The benefits of partial versus total breast reconstruction for women with macromastia. Plast Reconstr Surg. 2010;125(4):1051–6.PubMed
5.
Zurück zum Zitat Chang EI, Peled AW, Foster RD, et al. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg. 2012;255(6):1151–7.PubMedCrossRef Chang EI, Peled AW, Foster RD, et al. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg. 2012;255(6):1151–7.PubMedCrossRef
6.
Zurück zum Zitat Grubnik A, Benn C, Edwards G. Therapeutic mammaplasty for breast cancer: oncological and aesthetic outcomes. World J Surg. 2013;37(1):72–83.PubMedCrossRef Grubnik A, Benn C, Edwards G. Therapeutic mammaplasty for breast cancer: oncological and aesthetic outcomes. World J Surg. 2013;37(1):72–83.PubMedCrossRef
7.
Zurück zum Zitat Regano S, Hernanz F, Ortega E, Redondo-Figuero C, Gomez-Fleitas M. Oncoplastic techniques extend breast-conserving surgery to patients with neoadjuvant chemotherapy response unfit for conventional techniques. World J Surg. 2009;33(10):2082–6.PubMedCrossRef Regano S, Hernanz F, Ortega E, Redondo-Figuero C, Gomez-Fleitas M. Oncoplastic techniques extend breast-conserving surgery to patients with neoadjuvant chemotherapy response unfit for conventional techniques. World J Surg. 2009;33(10):2082–6.PubMedCrossRef
8.
Zurück zum Zitat Rainsbury RM. Surgery insight: oncoplastic breast-conserving reconstruction–indications, benefits, choices and outcomes. Nat Clin Pract Oncol. 2007;4(11):657–64.PubMedCrossRef Rainsbury RM. Surgery insight: oncoplastic breast-conserving reconstruction–indications, benefits, choices and outcomes. Nat Clin Pract Oncol. 2007;4(11):657–64.PubMedCrossRef
9.
Zurück zum Zitat Losken A, Pinell-White X, Hart AM, Freitas AM, Carlson GW, Styblo TM. The oncoplastic reduction approach to breast conservation therapy: benefits for margin control. Aesthet Surg J. 2014;34(8):1185–91.PubMedCrossRef Losken A, Pinell-White X, Hart AM, Freitas AM, Carlson GW, Styblo TM. The oncoplastic reduction approach to breast conservation therapy: benefits for margin control. Aesthet Surg J. 2014;34(8):1185–91.PubMedCrossRef
10.
Zurück zum Zitat Losken A, Elwood ET, Styblo TM, Bostwick J 3rd. The role of reduction mammaplasty in reconstructing partial mastectomy defects. Plast Reconstr Surg. 2002;109(3):968–75; discussion 976–7.PubMedCrossRef Losken A, Elwood ET, Styblo TM, Bostwick J 3rd. The role of reduction mammaplasty in reconstructing partial mastectomy defects. Plast Reconstr Surg. 2002;109(3):968–75; discussion 976–7.PubMedCrossRef
11.
Zurück zum Zitat Chang E, Johnson N, Webber B, et al. Bilateral reduction mammoplasty in combination with lumpectomy for treatment of breast cancer in patients with macromastia. Am J Surg. 2004;187(5):647–50; discussion 650–1.PubMedCrossRef Chang E, Johnson N, Webber B, et al. Bilateral reduction mammoplasty in combination with lumpectomy for treatment of breast cancer in patients with macromastia. Am J Surg. 2004;187(5):647–50; discussion 650–1.PubMedCrossRef
12.
Zurück zum Zitat Jones JA, Pu LL. Oncoplastic approach to early breast cancer in women with macromastia. Ann Plast Surg. 2007;58(1):34–8.PubMedCrossRef Jones JA, Pu LL. Oncoplastic approach to early breast cancer in women with macromastia. Ann Plast Surg. 2007;58(1):34–8.PubMedCrossRef
13.
Zurück zum Zitat Spear SL, Pelletiere CV, Wolfe AJ, Tsangaris TN, Pennanen MF. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg. 2003;111(3):1102–9.PubMedCrossRef Spear SL, Pelletiere CV, Wolfe AJ, Tsangaris TN, Pennanen MF. Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg. 2003;111(3):1102–9.PubMedCrossRef
14.
Zurück zum Zitat Caruso F, Catanuto G, De Meo L, et al. Outcomes of bilateral mammoplasty for early stage breast cancer. Eur J Surg Oncol. 2008;34(10):1143–7.PubMedCrossRef Caruso F, Catanuto G, De Meo L, et al. Outcomes of bilateral mammoplasty for early stage breast cancer. Eur J Surg Oncol. 2008;34(10):1143–7.PubMedCrossRef
15.
Zurück zum Zitat Hernanz F, Regano S, Vega A, Gomez Fleitas M. Reduction mammaplasty: an advantageous option for breast conserving surgery in large-breasted patients. Surg Oncol. 2010;19(4):e95–e102.PubMedCrossRef Hernanz F, Regano S, Vega A, Gomez Fleitas M. Reduction mammaplasty: an advantageous option for breast conserving surgery in large-breasted patients. Surg Oncol. 2010;19(4):e95–e102.PubMedCrossRef
16.
Zurück zum Zitat Currie A, Chong K, Davies GL. Using therapeutic mammoplasty to extend the role of breast-conserving surgery in women with larger or ptotic breasts. Ann R Coll Surg Engl. 2013;95(3):192–5.PubMedPubMedCentralCrossRef Currie A, Chong K, Davies GL. Using therapeutic mammoplasty to extend the role of breast-conserving surgery in women with larger or ptotic breasts. Ann R Coll Surg Engl. 2013;95(3):192–5.PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Iwuchukwu OC, Harvey JR, Dordea M, Critchley AC, Drew PJ. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery—a review. Surg Oncol. 2012;21(2):133–41.PubMedCrossRef Iwuchukwu OC, Harvey JR, Dordea M, Critchley AC, Drew PJ. The role of oncoplastic therapeutic mammoplasty in breast cancer surgery—a review. Surg Oncol. 2012;21(2):133–41.PubMedCrossRef
18.
Zurück zum Zitat Schaverien MV, Raine C, Majdak-Paredes E, Dixon JM. Therapeutic mammaplasty: extending indications and achieving low incomplete excision rates. Eur J Surg Oncol. 2013;39(4):329–33.PubMedCrossRef Schaverien MV, Raine C, Majdak-Paredes E, Dixon JM. Therapeutic mammaplasty: extending indications and achieving low incomplete excision rates. Eur J Surg Oncol. 2013;39(4):329–33.PubMedCrossRef
19.
Zurück zum Zitat Hart AM, Pinell-White X, Egro FM, Losken A. The psychosexual impact of partial and total breast reconstruction: a prospective 1-year longitudinal study. Ann Plast Surg. 2014. doi:10.1097/SAP.0000000000000152. Hart AM, Pinell-White X, Egro FM, Losken A. The psychosexual impact of partial and total breast reconstruction: a prospective 1-year longitudinal study. Ann Plast Surg. 2014. doi:10.​1097/​SAP.​0000000000000152​.
20.
Zurück zum Zitat McCulley SJ, Macmillan RD. Planning and use of therapeutic mammoplasty: Nottingham approach. Br J Plast Surg. 2005;58(7):889–901.PubMedCrossRef McCulley SJ, Macmillan RD. Planning and use of therapeutic mammoplasty: Nottingham approach. Br J Plast Surg. 2005;58(7):889–901.PubMedCrossRef
21.
Zurück zum Zitat Macmillan RD, James R, Gale KL, McCulley SJ. Therapeutic mammaplasty. J Surg Oncol. 2014;110(1):90–5.PubMedCrossRef Macmillan RD, James R, Gale KL, McCulley SJ. Therapeutic mammaplasty. J Surg Oncol. 2014;110(1):90–5.PubMedCrossRef
22.
Zurück zum Zitat Munhoz AM, Montag E, Gemperli R. Current aspects of therapeutic reduction mammaplasty for immediate early breast cancer management: an update. World J Clin Oncol. 2014;5(1):1–18.PubMedPubMedCentralCrossRef Munhoz AM, Montag E, Gemperli R. Current aspects of therapeutic reduction mammaplasty for immediate early breast cancer management: an update. World J Clin Oncol. 2014;5(1):1–18.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Miller CL, Feig SA, Fox JW 4th. Mammographic changes after reduction mammoplasty. AJR Am J Roentgenol. 1987;149(1):35–8.PubMedCrossRef Miller CL, Feig SA, Fox JW 4th. Mammographic changes after reduction mammoplasty. AJR Am J Roentgenol. 1987;149(1):35–8.PubMedCrossRef
24.
Zurück zum Zitat Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesth Plast Surg. 2001;25(4):283–5.CrossRef Danikas D, Theodorou SJ, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesth Plast Surg. 2001;25(4):283–5.CrossRef
25.
26.
Zurück zum Zitat Roberts JM, Clark CJ, Campbell MJ, Paige KT. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. Am J Surg. 2011;201(5):611–4.PubMedCrossRef Roberts JM, Clark CJ, Campbell MJ, Paige KT. Incidence of abnormal mammograms after reduction mammoplasty: implications for oncoplastic closure. Am J Surg. 2011;201(5):611–4.PubMedCrossRef
27.
Zurück zum Zitat Hall-Findlay EJ. A simplified vertical reduction mammaplasty: shortening the learning curve. Plast Reconstr Surg. 1999;104(3):748–59; discussion 760–3.PubMedCrossRef Hall-Findlay EJ. A simplified vertical reduction mammaplasty: shortening the learning curve. Plast Reconstr Surg. 1999;104(3):748–59; discussion 760–3.PubMedCrossRef
28.
Zurück zum Zitat Hall-Findlay EJ. Vertical breast reduction. Sem Plast Surg. 2004;18(3):211–24.CrossRef Hall-Findlay EJ. Vertical breast reduction. Sem Plast Surg. 2004;18(3):211–24.CrossRef
29.
Zurück zum Zitat Munhoz AM, Aldrighi CM. Therapeutic mammaplasty for centrally located breast tumors. Plast Reconstr Surg. 2006;118(3):812–3.PubMedCrossRef Munhoz AM, Aldrighi CM. Therapeutic mammaplasty for centrally located breast tumors. Plast Reconstr Surg. 2006;118(3):812–3.PubMedCrossRef
30.
Zurück zum Zitat McCulley SJ, Durani P, Macmillan RD. Therapeutic mammaplasty for centrally located breast tumors. Plast Reconstr Surg. 2006;117(2):366–73.PubMedCrossRef McCulley SJ, Durani P, Macmillan RD. Therapeutic mammaplasty for centrally located breast tumors. Plast Reconstr Surg. 2006;117(2):366–73.PubMedCrossRef
31.
Zurück zum Zitat Muir TM, Tresham J, Fritschi L, Wylie E. Screening for breast cancer post reduction mammoplasty. Clin Radiol. 2010;65(3):198–205.PubMedCrossRef Muir TM, Tresham J, Fritschi L, Wylie E. Screening for breast cancer post reduction mammoplasty. Clin Radiol. 2010;65(3):198–205.PubMedCrossRef
32.
Zurück zum Zitat Piper M, Warren Peled A, Price ER, Foster RD, Esserman LJ, Sbitany H. Mammographic changes after oncoplastic reduction mammoplasty. American Society of Plastic Surgeons Meeting. October, 2013. Piper M, Warren Peled A, Price ER, Foster RD, Esserman LJ, Sbitany H. Mammographic changes after oncoplastic reduction mammoplasty. American Society of Plastic Surgeons Meeting. October, 2013.
33.
Zurück zum Zitat Losken A, Styblo TM, Carlson GW, Jones GE, Amerson BJ. Management algorithm and outcome evaluation of partial mastectomy defects treated using reduction or mastopexy techniques. Ann Plast Surg. 2007;59(3):235–42.PubMedCrossRef Losken A, Styblo TM, Carlson GW, Jones GE, Amerson BJ. Management algorithm and outcome evaluation of partial mastectomy defects treated using reduction or mastopexy techniques. Ann Plast Surg. 2007;59(3):235–42.PubMedCrossRef
34.
Zurück zum Zitat Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 2003;237(1):26–34.PubMedPubMedCentralCrossRef Clough KB, Lewis JS, Couturaud B, Fitoussi A, Nos C, Falcou MC. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg. 2003;237(1):26–34.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Bogusevicius A, Cepuliene D, Sepetauskiene E. The integrated evaluation of the results of oncoplastic surgery for locally advanced breast cancer. Breast J. 2014;20(1):53–60.PubMedCrossRef Bogusevicius A, Cepuliene D, Sepetauskiene E. The integrated evaluation of the results of oncoplastic surgery for locally advanced breast cancer. Breast J. 2014;20(1):53–60.PubMedCrossRef
36.
Zurück zum Zitat Fitoussi AD, Berry MG, Fama F, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [outcomes article]. Plast Reconstr Surg. 2010;125(2):454–62.PubMedCrossRef Fitoussi AD, Berry MG, Fama F, et al. Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases [outcomes article]. Plast Reconstr Surg. 2010;125(2):454–62.PubMedCrossRef
37.
Zurück zum Zitat Wang F, Warren Peled A, Fowble B, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H. Effect modifiers of radiation risks in total skin-sparing mastectomy with immediate tissue expander-implant reconstruction. Plastic Surgery Research Council Meeting. May, 2015. Wang F, Warren Peled A, Fowble B, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H. Effect modifiers of radiation risks in total skin-sparing mastectomy with immediate tissue expander-implant reconstruction. Plastic Surgery Research Council Meeting. May, 2015.
Metadaten
Titel
Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without Reconstruction
verfasst von
Merisa Piper, MD
Anne Warren Peled, MD
Hani Sbitany, MD
Robert D. Foster, MD
Laura J. Esserman, MD, MBA
Elissa R. Price, MD
Publikationsdatum
01.01.2016
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4611-3

Weitere Artikel der Ausgabe 1/2016

Annals of Surgical Oncology 1/2016 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.